Innoviva, Inc. (INVA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

16.08

-0.07

(-0.43%)

At close: 04:00PM EDT

16.08

0.00

(0.00%)

After hours:

04:20PM EDT

Loading interactive chart…

GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
Simply Wall St.
Innoviva First Quarter 2024 Earnings: EPS: US$0.58 (vs US$0.51 in 1Q 2023)
Innoviva ( NASDAQ:INVA ) First Quarter 2024 Results Key Financial Results Revenue: US$77.5m (up 1.5% from 1Q 2023). Net...
Business Wire
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
BURLINGAME, Calif., May 08, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today reported financial results for the first quarter ended March 31, 2024, and highlighted select corporate achievements.